USD 1.03
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 | -4.52 Billion JPY | 36.58% |
2023 | -7.13 Billion JPY | -13.51% |
2022 | -6.28 Billion JPY | 31.51% |
2021 | -9.17 Billion JPY | -10.08% |
2020 | -8.33 Billion JPY | 5.25% |
2019 | -8.79 Billion JPY | 18.71% |
2018 | -10.82 Billion JPY | -4.28% |
2017 | -10.37 Billion JPY | -289.73% |
2016 | 5.46 Billion JPY | 155.59% |
2015 | -9.83 Billion JPY | -126.62% |
2014 | -4.34 Billion JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 FY | -4.52 Billion JPY | 36.58% |
2024 Q1 | -7.4 Billion JPY | -3.84% |
2024 Q4 | -4.52 Billion JPY | 1.84% |
2024 Q3 | -4.6 Billion JPY | 20.17% |
2024 Q2 | -5.77 Billion JPY | 22.06% |
2023 Q2 | -5.77 Billion JPY | 3.27% |
2023 Q1 | -5.96 Billion JPY | -16.95% |
2023 FY | -7.13 Billion JPY | -13.51% |
2023 Q4 | -7.13 Billion JPY | -23.05% |
2023 Q3 | -5.79 Billion JPY | -0.42% |
2022 Q4 | -5.1 Billion JPY | 21.25% |
2022 Q2 | -5.14 Billion JPY | 10.86% |
2022 Q1 | -5.76 Billion JPY | 8.23% |
2022 FY | -6.28 Billion JPY | 31.51% |
2022 Q3 | -6.47 Billion JPY | -26.05% |
2021 Q3 | -7.79 Billion JPY | -3.16% |
2021 Q2 | -7.55 Billion JPY | 8.47% |
2021 Q4 | -6.28 Billion JPY | 19.39% |
2021 FY | -9.17 Billion JPY | -10.08% |
2021 Q1 | -8.25 Billion JPY | 10.03% |
2020 Q4 | -9.17 Billion JPY | 5.86% |
2020 Q3 | -9.74 Billion JPY | -0.75% |
2020 Q2 | -9.67 Billion JPY | 9.56% |
2020 Q1 | -10.69 Billion JPY | -21.58% |
2020 FY | -8.33 Billion JPY | 5.25% |
2019 Q1 | -10.53 Billion JPY | 2.67% |
2019 Q4 | -8.79 Billion JPY | 60.08% |
2019 Q3 | -22.03 Billion JPY | -103.2% |
2019 FY | -8.79 Billion JPY | 18.71% |
2019 Q2 | -10.84 Billion JPY | -2.97% |
2018 FY | -10.82 Billion JPY | -4.28% |
2018 Q2 | -8.19 Billion JPY | 8.12% |
2018 Q3 | -7.7 Billion JPY | 5.98% |
2018 Q4 | -10.82 Billion JPY | -40.48% |
2018 Q1 | -8.91 Billion JPY | 14.07% |
2017 Q3 | -10.7 Billion JPY | -4.44% |
2017 FY | -10.37 Billion JPY | -289.73% |
2017 Q4 | -10.37 Billion JPY | 3.07% |
2017 Q2 | -10.24 Billion JPY | 1.14% |
2017 Q1 | -10.36 Billion JPY | -289.58% |
2016 Q3 | 567.94 Million JPY | 105.79% |
2016 Q2 | -9.81 Billion JPY | 2.11% |
2016 Q1 | -10.02 Billion JPY | -1.87% |
2016 FY | 5.46 Billion JPY | 155.59% |
2016 Q4 | 5.46 Billion JPY | 862.89% |
2015 FY | -9.83 Billion JPY | -126.62% |
2015 Q1 | -5.55 Billion JPY | -27.86% |
2015 Q2 | -5.18 Billion JPY | 6.57% |
2015 Q4 | -9.83 Billion JPY | 57.81% |
2015 Q3 | -23.31 Billion JPY | -349.6% |
2014 FY | -4.34 Billion JPY | 0.0% |
2014 Q4 | -4.34 Billion JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
AVITA Medical, Inc. | -26.23 Million USD | -17142.552% |
Manhattan Scientifics, Inc. | -7000.00 USD | -64614185.714% |
Össur hf. | 395.08 Million USD | 1244.831% |
QHSLab, Inc. | 1.72 Million USD | 261549.621% |
Wellstar International, Inc. | 51.36 Million USD | 8905.275% |
Össur hf. | 395.08 Million USD | 1244.831% |
CVR Medical Corp. | - USD | Infinity% |
Bionovate Technologies Corp | - USD | Infinity% |
Escalon Medical Corp. | 315.68 Thousand USD | 1432852.799% |
Aurora Spine Corporation | 1.9 Million USD | 237197.379% |
BrainsWay Ltd. | -10.32 Million USD | -43727.519% |
Lattice Biologics Ltd. | - USD | Infinity% |
BioElectronics Corporation | 14.82 Million USD | 30606.081% |
Hamilton Thorne Ltd. | 18.12 Million USD | 25053.05% |
Vivos Inc. | -1.59 Million USD | -283956.831% |
Kelyniam Global, Inc. | 487.33 Thousand USD | 928212.81% |
REMSleep Holdings, Inc. | -540.98 Thousand USD | -835965.998% |
Zecotek Photonics Inc. | 2.76 Million USD | 163831.47% |
Avitar, Inc. | 5.17 Million USD | 87565.919% |
Nanomix Corporation | 11.38 Million USD | 39813.211% |
EKF Diagnostics Holdings plc | -4.61 Million USD | -97860.418% |
Theraclion SA | -5.86 Million EUR | -77024.614% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Positron Corporation | 1.68 Million USD | 268228.142% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | 1.61 Million USD | 280884.832% |
Lombard Medical, Inc. | 11.49 Million USD | 39447.542% |
ALR Technologies Inc. | 19.14 Million USD | 23720.964% |
Stratec SE | 119.12 Million USD | 3896.873% |
Vycor Medical, Inc. | 1.05 Million USD | 429652.204% |
Heart Tronics, Inc. | 54.99 Thousand USD | 8224484.035% |
MicroPort Scientific Corporation | 673.58 Million USD | 771.485% |
VMS Rehab Systems, Inc. | 133.52 USD | 3387507589.515% |
NewCardio, Inc. | 2.41 Million USD | 187385.768% |
Guided Therapeutics, Inc. | 1.46 Million USD | 308416.502% |
Ingen Technologies, Inc. | 630.91 Thousand USD | 716990.758% |
Odyssey Group International, Inc. | 2.1 Million USD | 214684.435% |
CYduct Diagnostics, Inc. | 640.19 Thousand USD | 706601.28% |
Wellness Center USA, Inc. | 3.98 Million USD | 113586.872% |
SANUWAVE Health, Inc. | 30.14 Million USD | 15103.151% |
IR-Med Inc. | -606 Thousand USD | -746269.637% |
Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -32705.596% |
Polarean Imaging plc | -5.94 Million USD | -75961.088% |
United American Healthcare Corporation | -9.32 Million USD | -48393.621% |
ECGI Holdings, Inc. | 3.17 Million USD | 142725.463% |
Nu-Med Plus, Inc. | 93.19 Thousand USD | 4853416.737% |
Capital Group Holdings, Inc. | -3508.00 USD | -128933765.45% |
ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 1722373.416% |
Medical Supply International USA, Inc. | 216.6 Thousand USD | 2088203.856% |
Urologix, Inc. | 4.61 Million USD | 98106.501% |
Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 107549.406% |
Nexeon MedSystems Inc. | 3.33 Million USD | 135874.982% |
SS Innovations International, Inc. | 1.18 Million USD | 381676.672% |
Qualis Innovations, Inc. | 6671.00 USD | 67801029.396% |
Smith & Nephew plc | 2.77 Billion USD | 262.811% |
NIOX Group Plc | -23.93 Million USD | -18799.066% |
Fuse Medical, Inc. | 1.75 Million USD | 257748.128% |
Broncus Holding Corporation | -81.42 Million USD | -5454.812% |
Brain Scientific Inc. | 2.11 Million USD | 213875.498% |
Pressure BioSciences, Inc. | 22.67 Million USD | 20045.242% |
Health Logic Interactive Inc. | 39.55 Thousand USD | 11434233.023% |